Stay updated on PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page
- Check2 days agoChange DetectedLocations section expanded with new study sites across multiple countries (US, Canada, Australia, several European and Asian countries, and others) and added city-level centers. The update provides detailed participating centers and locations for the Duchenne Muscular Dystrophy study.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange Detected- Revision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedRemoved the banner about government funding status and potential downtime. The study details and participation information remain unchanged.SummaryDifference0.3%

- Check60 days agoChange DetectedMinor UI adjustments and date updates were observed on the Study Details page, with core study content and outcomes remaining unchanged.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page has been updated to show more locations and exact institutions ( UF/GA lines and UCLA ), with a new total of 51 locations and updated timestamps, replacing older counts of 49 and earlier last-update labels.SummaryDifference1%

- Check81 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.